Biomagnetism of tumor in rats with Guerin’s carcinoma after injection of ferromagnetic nanocomposite (Ferroplat): contactless measurement


  • I.N. Todor R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology
  • N.Yu. Lukianova R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology
  • M.А. Primin V.M. Glushkov Institute of Cybernetics
  • I.V. Nedayvoda V.M. Glushkov Institute of Cybernetics
  • V.F. Chekhun R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology



cisplatinum, ferromagnetic nanoparticles, malignant tumor, SQUID-magnetometry


Summary. Aim: In order to develop fundamentally new technologies for non-invasive and safer diagnosis of cancer, we aimed to detect non-contact magnetic signals from a malignant tumor in animals treated or not-treated with the ferromagnetic nanocomposite Ferroplat. Materials and Methods: Guerin’s carcinoma was used as a model of tumor growth. The biomagnetism of the tumor was evaluated in the dynamics of its growth. Ten days after tumor transplantation, Ferroplat was administered intravenously to half of the animals with the tumor and to half of the control animals. The magnitude of the magnetic signals was determined 1 h and every two days after administration of the nanocomposite using a Superconducting Quantum Interference Device magnetometer of the original design. Results: We have found that the magnetic signals coming from the tumor are significantly higher compared to control tumor-free animals. Intravenous administration of a ferromagnetic nanocomposite (Ferroplat: Fe3O4 + cisplatinum) led to a significant increase of the magnetic signal, especially in the tumor tissue, and inhibition of Guerin’s carcinoma growth. Ferromagnetic nanoparticles (32.7 nm) are retained in malignant cells for a longer time than in normal ones. Conclusion: Tumor cells accumulate iron nanoparticles more intensively than normal ones. Nanocomposite Ferroplat can be used for a targeted delivery of cisplatin to malignant cells.


Hathaway HJ, Butler KS, Adolphi NL, et al. Detection of breast cancer cells using targeted magnetic nanoparticles and ultra-sensitive magnetic field sensors. Breast Cancer Res 2011; 13: R108.

Yao L, Xu S. Detection of magnetic nanomaterials in molecular imaging and diagnosis applications. Nanotechnol Rev 2014; 3: 247–68.

De Haro LP, Karaulanov T, Vreeland EC, et al. Magnetic relaxometry as applied to sensitive cancer detection and localization. Biomed Tech (Berl) 2015; 60: 445–55.

Körber R, Storm J-H, Seton H, et al. SQUIDs in biomagnetism: a roadmap towards improved healthcare. Supercond Sci Technol 2016: 29: 1–30.

Huang MX, Anderson B, Huang CW, et al. Development of advanced signal processing and source imaging methods for superparamagnetic relaxometry. Phys Mol Biol 2017; 62: 734–57.

Clarke J, Lee Y-H, Schneiderman J. Focus on SQUIDs in Biomagnetism. Superconductor Sci Tech 2018; 31: 1–7.

Richter H, Kettering M, Wiekhorst F, et al. Magnetorelaxometry for localization and quantification of magnetic nanoparticles for thermal ablation studies. Phys Med Biol 2010; 55: 623–33.

Liebl M, Wiekhorst F, Eberbeck D, et al. Magnetorelaxometry procedures for quantitative imaging and characterization of magnetic nanoparticles in biomedical applications. Biomed Tech (Berl) 2015; 60: 427–43.

Chieh JJ, Huang KW, Lee YY, et al. Dual-imaging model of SQUID biosusceptometry for locating tumors targeted using magnetic nanoparticles. J Nanobiotechnology. 13:11. doi: 10.1186/s12951-015-0069-5.

Arriortua OK, Garaio E, Herrero de la Parte B, et al. Antitumor magnetic hyperthermia induced by RGD-functionalized Fe3O4 nanoparticles, in an experimental model of colorectal liver metastases. J Nanotechnol 2016; 7: 1532–42.

Chang D, Lim M, Goos JACM, et al. Biologically targeted magnetic hyperthermia: potential and limitations. Front Pharmacol 2018; 9: 831. doi: 10.3389/fphar.2018.00831.

Balejcikova L, Molcan M, Kovac J, et al. Hyperthermic effect in magnetoferritin aqueous colloidal solution. J Mol Liq 2019; 283: 39–44.

Toyokuni S. Role of iron in cancerogenesis: Cancer as a ferrotoxic disease. Cancer Sci 2009; 100: 9–16.

Anderson GJ, McLaren GD. Iron Physiology and Pathophysiology in Humans. Springer Science & Business Media, 2012: 703 p.

Lamy PJ, Durigova A, Jacot W. Iron homeostasis and anemia markers in early breast cancer. Clin Chim Acta 2014; 434: 434–40.

Torti SV, Torti FM. Iron and cancer: more ore to be mined. Natl Rev Cancer 2013; 13: 342–55.

Torti SV, Torti FM. Cellular iron metabolism in prognosis and therapy of breast cancer. Crit Rev Oncog 2013; 18: 435–48.

Gorbyk PP, Chekhun VF. Nanocomposites of medicobiologic destination: reality and perspectives for oncology. Functional materials 2012; 19: 145–56.

Hosu O, Tertis M, Cristea C. Implication of magnetic nanoparticles in cancer detection, screening and treatment. Magnetochemistry 2019; 5, 55; doi:10.3390/magnetochemistry5040055.

Jabalera Y, Garcia-Pinel B, Ortiz R, et al. Oxaliplatin-biomimetic magnetic nanoparticle assemblies for colon cancer-targeted chemotherapy: an in vitro study. Pharmaceutics 2019; 11, 395; doi:10.3390/pharmaceutics11080395.

Nogueira J, Soares SF, Amorim CO, et al. Magnetic driven nanocarriers for pH-responsive doxorubicin release in cancer therapy. Molecules 2020; 25, 333; doi:10.3390/molecules25020333.

Ferreira M, Sousa J, Pais A, et al. The role of magnetic nanoparticles in cancer nanotheranostics. Materials 2020; 13, 266; doi:10.3390/ma13020266.




How to Cite

Todor, I., Lukianova, N., Primin, M., Nedayvoda, I., & Chekhun, V. (2023). Biomagnetism of tumor in rats with Guerin’s carcinoma after injection of ferromagnetic nanocomposite (Ferroplat): contactless measurement. Experimental Oncology, 42(3), 204–207.



Original contributions

Most read articles by the same author(s)

1 2 > >>